TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARICEPT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ARICEPT

ST13

US500000074679151

Class

5

Filing

74679151

Registration

2065647

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

05/28/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

05/23/1995

Registration date

05/27/1997

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/17/2017

Last transaction

05/28/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/03/1997

First use in commerce

01/03/1997

Drawing code

1

Owner type

03

Owner location

TOKYO, JP

Examiner

SMITH, LAURA E

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

EISAI R&D MANAGEMENT CO., LTD.
EISAI COMPANY LIMITED
EISAI COMPANY LIMITED <EISAI CO., LTD.>
EISAI COMPANY LIMITED [EISAI CO., LTD.]

Representatives

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for the treatment of cerebral disorders

Publications

History of USPTO decisions and trademark events.

31 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/27/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/17/2017

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/17/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/17/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/17/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

03/23/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/26/2007

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/26/2007

PLGL

ASSIGNED TO PARALEGAL

06/20/2007

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

05/29/2007

E89R

TEAS SECTION 8 & 9 RECEIVED

05/29/2007

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/23/2007

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/16/2007

CFIT

CASE FILE IN TICRS

05/22/2006

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/14/2003

PR23

RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 15

09/16/2002

MAIL

PAPER RECEIVED

09/16/2002

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

08/27/2002

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

06/19/2002

MAIL

PAPER RECEIVED

06/19/2002

R.PR

REGISTERED-PRINCIPAL REGISTER

05/27/1997

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/04/1997

DOCK

ASSIGNED TO EXAMINER

04/01/1997

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/27/1997

IUAF

USE AMENDMENT FILED

02/27/1997

EX1G

SOU EXTENSION 1 GRANTED

11/15/1996

EXT1

SOU EXTENSION 1 FILED

09/04/1996

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

04/02/1996

PUBO

PUBLISHED FOR OPPOSITION

01/09/1996

NPUB

NOTICE OF PUBLICATION

12/08/1995

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/12/1995

Continuous trademark protection

Get notified about every new filing that threatens ARICEPT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.